An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, phase III ...

Please provide your email address to receive an email when new articles are posted on . A shorter radiation therapy regimen conferred similar outcomes as standard of care for women undergoing breast ...

An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, Phase III ...

WASHINGTON, DC — Radiation oncologists can feel confident offering hypofractionated treatment regimens to treat breast cancer in patients who are planning breast reconstruction after mastectomy, ...

A new study suggests that many women with early-stage breast cancer may not need radiation after a mastectomy, thanks to advances in modern cancer treatment. The international clinical trial followed ...

More than half of breast cancer patients receive radiation as part of their treatment, but it may not help those with early-stage cancer, new research shows. Women who received a radiation course ...

A study of 1,600 women with breast cancer found no difference in 10-year survival with or without radiation Only 29 had cancer return in the chest area, even without radiation Results suggest that ...

Please provide your email address to receive an email when new articles are posted on . Survival and recurrence rates appeared similar between patients who received hypofractionation and conventional ...

"Given the rapid adoption of biologically tailored neoadjuvant systemic therapy and the de-escalation of axillary surgery with the use of sentinel lymph node biopsy or targeted axillary dissection, ...

PURPOSE: To determine the risk of second malignancies after lumpectomy and radiation therapy (LRT), and to compare it with that in a similar cohort of early-stage breast cancer patients undergoing ...

While radiation has been a standard treatment for breast cancer patients since the early 20th century, a new study shows that it does not significantly improve survival for women with early-stage ...